Moneycontrol PRO
you are here: HomeNewsTrends

Mankind Pharma to donate Rs 100 crore to families of deceased frontline COVID warriors

The company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma said in a statement.

April 26, 2021 / 05:01 PM IST
(Representative image: Reuters)

(Representative image: Reuters)

Drug firm Mankind Pharma on April 26 said it will donate Rs 100 crore tor the families of deceased doctors, police officers, pharmacists, and other healthcare workers who have lost their lives fighting the pandemic.

The company plans to start releasing the money with immediate effect and hopes to complete it within three months, Mankind Pharma said in a statement.

As the country continues to grapple with the second wave of coronavirus pandemic, healthcare and frontline workers are racing against time to contain its spread. Many dedicated heroes have lost their lives in the process, it added.

"As a responsible organisation, Mankind Pharma is standing alongside the families of these heroes and will donate Rs 100 crore to support them,” the company said.

On the initiative, Mankind Pharma MD and Vice Chairman Rajeev Juneja said, being the first line of defence they are highly exposed to this deadly disease. Many have lost their lives fighting the pandemic and protecting us.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"As a homage to them, we have pledged a fund of Rs 100 crore to support and care for the families of these lost warriors. This is not our duty, but a debt we owe them. Because they are truly our hope,” he added.

The company knows it can never do enough to replace their void but it can at least try to help them ride through these trying times, Juneja said.

first published: Apr 26, 2021 05:01 pm